Showing results (151-160 of 163) with videos related to

Sort By:
Pageof 17
Respiratory Investigation|May 3, 2021
Quantification of BIM mRNA in circulating tumor cells of osimertinib-treated patients with EGFR mutation-positive lung cancerKazutoshi Isobe, Takahiro Yoshizawa, Muneyuki Sekiya, et al.
Lung Cancer (Amsterdam, Netherlands)|December 12, 2018
Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinomaTakashi Sakai, Keiju Aokage, Shinya Neri, et al.
Pathology International|July 25, 2009
Malignant pleural mesothelioma: clinicopathology of 16 extrapleural pneumonectomy patients with special reference to early stage featuresKenzo Hiroshima, Toshikazu Yusa, Toru Kameya, et al.
Cancer Genomics & Proteomics|November 4, 2016
Association of BIM Deletion Polymorphism and BIM-γ RNA Expression in NSCLC with EGFR MutationKazutoshi Isobe, Atsushi Kakimoto, Tetsuo Mikami, et al.
Cancer Genomics & Proteomics|January 7, 2015
Usefulness of nanofluidic digital PCR arrays to quantify T790M mutation in EGFR-mutant lung adenocarcinomaKazutoshi Isobe, Yoshinobu Hata, Naobumi Tochigi, et al.
Oncology Reports|May 17, 2018
PD-L1 mRNA expression in EGFR-mutant lung adenocarcinomaKazutoshi Isobe, Atsushi Kakimoto, Tetuo Mikami, et al.
Molecular and Clinical Oncology|December 2, 2015
Thymoma exhibiting spontaneous regression in size, pleural effusion and serum cytokeratin fragment level: A case reportKenta Furuya, Kazutoshi Isobe, G O Sano, et al.
Internal Medicine (Tokyo, Japan)|March 4, 2014
An anomalous unilateral single pulmonary vein associated with a bone morphogenetic protein receptor II gene mutationKazuya Koyama, Go Sano, Yoshinobu Hata, et al.
International Journal of Oncology|June 18, 2015
[Corrigendum] Aberrant methylation of CXCL12 in non-small cell lung cancer is associated with an unfavorable prognosisMakoto Suzuki, Sherif Mohamed, Takahiro Nakajima, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 17, 2014
Clinical significance of BIM deletion polymorphism in non-small-cell lung cancer with epidermal growth factor receptor mutationKazutoshi Isobe, Yoshinobu Hata, Naobumi Tochigi, et al.
Pageof 17